Establishment of a value assessment framework for orphan medicinal products in China
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Establishment of a value assessment framework for orphan medicinal products in China ; volume:19 ; number:1 ; day:20 ; month:10 ; year:2024 ; pages:1-11 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (20.10.2024), 1-11, 12.2024
- Creator
-
Chen, Handong
Xiang, Yuliang
Tang, Xian
Hu, Ming
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-024-03393-6
- URN
-
urn:nbn:de:101:1-2501082105254.049051553134
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Handong
- Xiang, Yuliang
- Tang, Xian
- Hu, Ming
- SpringerLink (Online service)
Other Objects (12)
The European challenges of funding orphan medicinal products
Comparing access to orphan medicinal products in Europe
Clinical evidence for orphan medicinal products-a cause for concern?
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
Natural products in medicinal chemistry
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
The European challenges of funding orphan medicinal products
Comparing access to orphan medicinal products in Europe
Clinical evidence for orphan medicinal products-a cause for concern?
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
Natural products in medicinal chemistry
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
The European challenges of funding orphan medicinal products
Comparing access to orphan medicinal products in Europe
Clinical evidence for orphan medicinal products-a cause for concern?
Off-label use of orphan medicinal products: a Belgian qualitative study
Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool
Evidence supporting regulatory-decision making on orphan medicinal products authorisation in Europe: methodological uncertainties
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
Natural products in medicinal chemistry